Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple...
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial
About this item
Full title
Author / Creator
Mateos, Maria-Victoria , Cavo, Michele , Blade, Joan , Dimopoulos, Meletios A , Suzuki, Kenshi , Jakubowiak, Andrzej , Knop, Stefan , Doyen, Chantal , Lucio, Paulo , Nagy, Zsolt , Pour, Ludek , Cook, Mark , Grosicki, Sebastian , Crepaldi, Andre , Liberati, Anna Marina , Campbell, Philip , Shelekhova, Tatiana , Yoon, Sung-Soo , Iosava, Genadi , Fujisaki, Tomoaki , Garg, Mamta , Krevvata, Maria , Chen, Ying , Wang, Jianping , Kudva, Anupa , Ukropec, Jon , Wroblewski, Susan , Qi, Ming , Kobos, Rachel and San-Miguel, Jesus
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Standard-of-care treatment for patients with newly diagnosed multiple myeloma includes combination therapies for patients who are not eligible for autologous stem-cell transplantation. At the primary analysis for progression-free survival of the phase 3 ALCYONE trial, progression-free survival was significantly longer with daratumumab in combinatio...
Alternative Titles
Full title
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial
Authors, Artists and Contributors
Author / Creator
Cavo, Michele
Blade, Joan
Dimopoulos, Meletios A
Suzuki, Kenshi
Jakubowiak, Andrzej
Knop, Stefan
Doyen, Chantal
Lucio, Paulo
Nagy, Zsolt
Pour, Ludek
Cook, Mark
Grosicki, Sebastian
Crepaldi, Andre
Liberati, Anna Marina
Campbell, Philip
Shelekhova, Tatiana
Yoon, Sung-Soo
Iosava, Genadi
Fujisaki, Tomoaki
Garg, Mamta
Krevvata, Maria
Chen, Ying
Wang, Jianping
Kudva, Anupa
Ukropec, Jon
Wroblewski, Susan
Qi, Ming
Kobos, Rachel
San-Miguel, Jesus
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2336999199
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2336999199
Other Identifiers
ISSN
0140-6736
E-ISSN
1474-547X
DOI
10.1016/S0140-6736(19)32956-3
